Moonlight, cameras, action: recreating Oscar-nomination films by the Moon
With the 91st Academy Awards set to take place in the early hours of Monday (25 February GMT), Life Science Centre has been inspired to play homage to Oscar-nominated movies.
The International Centre for Life opened in 2000, born out of an entrepreneurial spirit and a commitment to creating a self-sustaining science village.
Almost 600 people from 35 countries work here: researchers, doctors and nurses work alongside people in the fields of education, public engagement and business. What unites everyone is a passion for science. On site partners include Newcastle University, who chose Life for the location of their Institute of Genetic Medicine; the NHS Newcastle Fertility Centre; the NHS Northern Genetics Service and several young and vibrant biotechnology companies.
Biomedicine West Wing is a purpose built centre of 60,000 sq ft. providing accommodation for new and established biotechnology companies. The Incubator Suite is designed to allow start up and spin out companies to become established and realise potential commercial success. A shared laboratory facility is available for use of the incubator tenants. Advice and support is provided to assist new companies to grow. NHS Newcastle Fertility Centre and Newcastle University are located here along with OJ-Bio.
Biomedicine East Wing is home to Newcastle University and NHS Northern Genetics Service.
Biomedicine East Wing is home to Newcastle University and NHS Northern Genetics Service.
The NHS Newcastle Fertility Centre
Established in 1991, this was the first centre in the North East to provide IVF treatment and support for patients that have fertility related problems. It provides state-of-the-art treatments delivered by highly skilled clinical and embryology staff.
The clinic has gained the reputation for pioneering new technologies that have been adopted internationally. Most couples in the North East can be seen as NHS patients and the Centre receives referrals via GPs. A fee paying service is available for those who are not eligible for NHS funded treatment.
The clinic has gained the reputation for pioneering new technologies that have been adopted internationally. Most couples in the North East can be seen as NHS patients and the Centre receives referrals via GPs. A fee paying service is available for those who are not eligible for NHS funded treatment.
Established in 2001 as the Institute of Human Genetics, the Institute of Genetic Medicine is one of seven Newcastle University research institutes within the Faculty of Medical Sciences and Newcastle Biomedicine. It encompasses a total of over 150 staff and postgraduate students who, together with almost 150 Northern Genetics Service NHS staff, occupy purpose-built accommodation at Life.
The Institute was renamed in 2011 to reflect the increased emphasis on world-leading translational research carried out within seven research themes spanning clinical medicine. IGM’s mission is: to harness genetic, developmental and cell biology to understand and treat human disease by developing and implementing new therapies.
Part of the Institute of Genetic Medicine, the Northern Genetics Service provides comprehensive and fully integrated clinical and laboratory services that can help reduce the incidence of illnesses associated with genetic disease. The research done at Life is leading to a much better understanding of the role that genes play in common diseases such as cancer and heart disease. The Northern Genetics Service provides a diagnostic and "genetic counselling" service across the region for people with problems or susceptibilities relating to genetic disorders.
These disorders include single gene disorders such as muscular dystrophy, Huntington’s disease and cystic fibrosis plus birth defects and/or learning disabilities with a genetic component. The Newcastle Muscle Centre at the Institute of Genetic Medicine is one of three centres in England for the diagnosis and management of inherited muscle diseases supported by the British Muscular Dystrophy Campaign.
OJ-Bio
OJ-Bio, based in Biomedicine West, is a joint venture between Orla Protein Technologies Ltd and Japan Radio Company Ltd (JRC). The company's diagnostic platform allows rapid measurement of disease markers and the electronic storage and wireless transmission of results - ideal for remote use and near-patient testing.
Orla Protein Technologies
Since its foundation in 2003, Orla Protein Technologies has built a solid reputation in the Life Sciences Industry through cutting-edge research and a commitment to innovation. They focus on recombinant protein design, engineering and manufacture particularly for surface applications.
NorthGene
NorthGene specialises in human identification services including DNA paternity and relationship testing for peace of mind, legal, immigration and forensic cases.
NewGene
Established through a partnership between the Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University, NewGene is a pioneer in developing, validating and delivering molecular diagnostics using the latest high throughput sequencing and genotyping technologies.
Newcells Biotech
Newcells Biotech are experts in the production of induced pluripotent stem cells (iPSCs) and their differentiation into a wide range of reliable and reproducible cell and tissue types.